uniQure N.V.
Viés de baixa

QURE 2M

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands
Beyond Technical AnalysisQURETrend AnalysisWave Analysis

Aviso legal